MX5879E - Procedimiento para la elaboracion de preparaciones farmaceuticas transdermicas en la forma de peliculas de poliacrilato - Google Patents

Procedimiento para la elaboracion de preparaciones farmaceuticas transdermicas en la forma de peliculas de poliacrilato

Info

Publication number
MX5879E
MX5879E MX808826U MX882680U MX5879E MX 5879 E MX5879 E MX 5879E MX 808826 U MX808826 U MX 808826U MX 882680 U MX882680 U MX 882680U MX 5879 E MX5879 E MX 5879E
Authority
MX
Mexico
Prior art keywords
transdermic
elaboration
procedure
pharmaceutical preparations
polyacrylate films
Prior art date
Application number
MX808826U
Other languages
English (en)
Inventor
Herbert Stricker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6071291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX5879(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of MX5879E publication Critical patent/MX5879E/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S602/00Surgery: splint, brace, or bandage
    • Y10S602/90Method of making bandage structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
MX808826U 1979-05-21 1980-05-20 Procedimiento para la elaboracion de preparaciones farmaceuticas transdermicas en la forma de peliculas de poliacrilato MX5879E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792920500 DE2920500A1 (de) 1979-05-21 1979-05-21 Pharmazeutische zubereitung in form eines polyacrylatfilmes

Publications (1)

Publication Number Publication Date
MX5879E true MX5879E (es) 1984-08-16

Family

ID=6071291

Family Applications (1)

Application Number Title Priority Date Filing Date
MX808826U MX5879E (es) 1979-05-21 1980-05-20 Procedimiento para la elaboracion de preparaciones farmaceuticas transdermicas en la forma de peliculas de poliacrilato

Country Status (17)

Country Link
US (1) US4409206A (es)
EP (1) EP0020905B1 (es)
JP (1) JPS5636413A (es)
AT (1) ATE8459T1 (es)
AU (1) AU537874B2 (es)
CA (1) CA1136045A (es)
DD (1) DD150849A5 (es)
DE (2) DE2920500A1 (es)
DK (1) DK154538C (es)
ES (1) ES8200558A1 (es)
FI (1) FI73884C (es)
IL (1) IL60114A (es)
MX (1) MX5879E (es)
NO (1) NO153637C (es)
PL (1) PL125847B1 (es)
YU (1) YU135980A (es)
ZA (1) ZA803009B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
JPS57116011A (en) * 1981-01-08 1982-07-19 Nitto Electric Ind Co Ltd Pharmaceutical preparation
JPS6059207B2 (ja) * 1981-03-13 1985-12-24 日東電工株式会社 複合製剤の製法
JPS57150503U (es) * 1981-03-17 1982-09-21
JPS5838213A (ja) * 1981-08-31 1983-03-05 Nitto Electric Ind Co Ltd 医薬製剤
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
US4608249A (en) * 1982-11-02 1986-08-26 Nitto Electric Industrial Co., Ltd. Hydrophilic therapeutic material
JPS6045522B2 (ja) * 1982-12-08 1985-10-09 憲司 中村 化粧用具
CA1239318A (en) * 1983-04-27 1988-07-19 Hans R. Hoffmann Pharmaceutical product preferably in medical bandage form and process for producing them
DE3486088T2 (de) * 1983-08-31 1993-09-30 Sky Polymers Einspritzbare physiologisch unbedenkliche polymerzusammensetzungen.
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
DE3344618C2 (de) * 1983-12-09 1985-12-05 EGWA Apothekergenossenschaft eG, 7144 Asperg Verbandsstoff und Verfahren zu dessen Herstellung
US5364628A (en) * 1985-05-31 1994-11-15 Sandoz Ltd. Pharmaceutical compositions
DE3564073D1 (en) * 1984-06-23 1988-09-08 Beiersdorf Ag Self-adhesive plaster
US4649075A (en) * 1984-08-09 1987-03-10 Leonora Jost Transdermal and transmucosal vortexed foam devices and the method of making
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4685455A (en) * 1984-10-16 1987-08-11 Akzo Nv Watervapor-permeable, pressure sensitive, antiseptic wound covering material
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
CA1288698C (en) * 1985-08-30 1991-09-10 Yie W. Chien Transdermal anti-anginal pharmaceutical dosage
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
US4765974A (en) * 1985-12-24 1988-08-23 Nitto Electric Industrial Co., Ltd. Preparation for percutaneous administration
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
CH672888A5 (es) * 1986-11-07 1990-01-15 Mepha Ag
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US4857313A (en) * 1987-05-28 1989-08-15 Warner-Lambert Company Transdermal drug delivery device comprising copolymers of N-morpholinoethyl methacrylate and 2-hydroxylmethacrylate
DE3728563A1 (de) * 1987-08-27 1989-03-09 Pohl Boskamp Gmbh Chem Pharma N-alkylscopolaminiumsalz und nitroglycerin enthaltendes arzneimittel, verfahren zu dessen herstellung und dessen verwendung
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JPH07116035B2 (ja) * 1987-12-08 1995-12-13 塩野義製薬株式会社 被膜形成性抗真菌剤組成物
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
US6559186B1 (en) 1990-02-26 2003-05-06 Arc 1, Inc. Compositions and methods of treatment of sympathetically maintained pain
JPH0453907U (es) * 1990-09-14 1992-05-08
US5173302A (en) * 1990-09-28 1992-12-22 Medtronic, Inc. Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
DE4032096C2 (de) * 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Verwendung emulgatorfreier Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe
KR950701508A (ko) * 1992-06-11 1995-04-28 챨스 디 에버트 경피식 약물수송을 조절하기 위한 글리세린의 용도(the use of glycerin in moderating transdermal drug delivery)
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5388588A (en) * 1993-05-04 1995-02-14 Nabai; Hossein Biopsy wound closure device and method
US5325857A (en) * 1993-07-09 1994-07-05 Hossein Nabai Skin biopsy device and method
US5394886A (en) * 1993-09-20 1995-03-07 Nabai; Hossein Skin biopsy plug and method
DE4336299A1 (de) * 1993-10-25 1995-05-11 Arbo Robotron Medizin Technolo Gelkörper zur percutanen Verabreichung, insbesondere von Medikamenten
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
US5562653A (en) * 1994-11-16 1996-10-08 Hercules Incorporated Medical devices composed of low ceiling temperature polymers
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
US6365178B1 (en) * 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
ES2179646T3 (es) 1998-04-27 2003-01-16 Surmodics Inc Revestimiento que libera un agente bioactivo.
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
DE10114247A1 (de) * 2001-03-22 2002-10-10 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Polymer-Kombination
US8496960B2 (en) * 2001-10-23 2013-07-30 Purdue Pharma L.P. Terazosin transdermal device and methods
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
US7541048B2 (en) 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
CN101146523B (zh) 2004-10-21 2010-12-29 杜雷科特公司 透皮给药系统
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US20080097380A1 (en) * 2006-09-21 2008-04-24 Li Kasey K Method and apparatus for creating variable stiffness and/or reduction of soft tissue
EP1920768A1 (en) 2006-11-10 2008-05-14 Abbott GmbH & Co. KG Solid dosage form with a film containing an active substance, as well as its method of production
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CN102099020B (zh) * 2008-05-30 2013-09-18 迈兰股份有限公司 稳定的透皮药物递送系统
AU2009302853B2 (en) 2008-10-06 2014-09-11 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
CA2911613A1 (en) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
JP6596432B2 (ja) 2014-01-20 2019-10-23 メリアル インコーポレイテッド 局所送達製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017747B (de) * 1953-06-10 1957-10-17 Bofors Ab Fluessiges Verbandmaterial
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US3579628A (en) * 1967-07-03 1971-05-18 Johnson & Johnson Dressing film
NL6902314A (es) * 1969-02-13 1970-08-17
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3699963A (en) * 1969-10-31 1972-10-24 Alza Corp Therapeutic adhesive patch
GB1394990A (en) * 1971-08-12 1975-05-21 Hydrophilics Int Inc Copolymers and compositions containing copolymers
DE2214306A1 (de) * 1972-03-24 1973-09-27 Dynamit Nobel Ag Wundfilm-spray
SE369276B (es) * 1972-12-27 1974-08-19 U Sweger
US4076798A (en) * 1975-05-29 1978-02-28 American Cyanamid Company High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition
US4013112A (en) * 1975-09-02 1977-03-22 International Harvester Company Anchor plate tire having a sub-lug equipped anchor plate
IT1085524B (it) * 1977-03-22 1985-05-28 Snam Progetti Materiali e fibre porose biocompatibili in grado di inglobare sostanze di interesse biologico e metodi per il loro ottenimento
DE2725261C2 (de) * 1977-06-03 1986-10-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally

Also Published As

Publication number Publication date
CA1136045A (en) 1982-11-23
ES491621A0 (es) 1981-11-01
FI73884B (fi) 1987-08-31
DE2920500A1 (de) 1980-11-27
EP0020905A1 (de) 1981-01-07
FI73884C (fi) 1987-12-10
DE3068570D1 (en) 1984-08-23
NO153637B (no) 1986-01-20
DK175680A (da) 1980-11-22
EP0020905B1 (de) 1984-07-18
ATE8459T1 (de) 1984-08-15
FI801614A (fi) 1980-11-22
JPH0220606B2 (es) 1990-05-10
YU135980A (en) 1983-12-31
PL125847B1 (en) 1983-06-30
JPS5636413A (en) 1981-04-09
AU5858380A (en) 1980-11-27
IL60114A0 (en) 1980-07-31
NO153637C (no) 1986-05-21
NO801490L (no) 1980-11-24
AU537874B2 (en) 1984-07-19
PL224368A1 (es) 1981-07-10
IL60114A (en) 1983-09-30
ES8200558A1 (es) 1981-11-01
DK154538B (da) 1988-11-28
ZA803009B (en) 1982-01-27
DD150849A5 (de) 1981-09-23
DK154538C (da) 1989-04-17
US4409206A (en) 1983-10-11

Similar Documents

Publication Publication Date Title
MX5879E (es) Procedimiento para la elaboracion de preparaciones farmaceuticas transdermicas en la forma de peliculas de poliacrilato
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
ATE64297T1 (de) Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung.
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
PT814796E (pt) Uso de um farmaco r-aine numa composicao protectora para o tratamento do cancro colorectal
FI19991893A (fi) Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
NO151119C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive ornithin og argininsalter av forgrenede ketosyrer
DE58902457D1 (de) Retardierte arzneiform und verfahren zu ihrer herstellung.
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ES2033021T3 (es) Agente con efecto destructivo a tumores malignos, procedimiento para su obtencion y preparacion para la aplicacion en la terapia de enfermos de cancer.
SE8701479D0 (sv) Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
ES539500A0 (es) Procedimiento para preparar una formulacion liquida farma- ceutica de formas de dosificacion de liberacion controlada doblemente revestidas
AR214234A1 (es) Dispositivo para la administracion de sustancias medicamentosas
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
SE7904485L (sv) Medicin innehallande para-aminobensoesyra-n-d-xylosid sasom en aktiv bestandsdel
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
ES490453A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica de quinazolinonas analgesicas
DK313281A (da) Anordning til indgift af medicinsk aktive substanser
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
DK400887D0 (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
DK0621789T3 (da) Farmaceutiske pentapeptidpræparater og fremgangsmåder til anvendelse deraf
KR970009798A (ko) 포유동물에서의 유리 라디칼 손상을 감소시키기 위해 철 킬레이트화 화합물을 사용하는 방법